Researchers found that higher methylation values of four genes (RASSF1A, CDH1, CDH13, and APC) were significantly associated with several traits of poorer outcome (tumor stage, growth pattern, muscle invasion, and tumor grade). The gene discussed is CDH1; the disease is neoplasm.